Heinrich, Luján, Stansbury Welcome Over $1 Million In Federal Funding To Support Chronic Disease Prevention In Tribes

WASHINGTON — U.S. Senators Martin Heinrich (D-N.M.) and Ben Ray Luján (D-N.M.) and U.S. Representative Melanie Stansbury (D-N.M.) are welcoming $1,240,625 in federal funding heading to the Albuquerque Area Indian Health Board, Inc., to support healthy behaviors and emphasize strategies to reduce chronic disease risk factors in Tribes.
“Federal investments play a key role in empowering Tribal health providers and advocates to better address the chronic disease risk factors that disproportionately impact Native Americans,” said Heinrich. “That’s why I’m proud to welcome this federal investment that will provide Tribes with the resources they need to promote healthy living and chronic disease prevention.”
“The health of Native communities in New Mexico must remain a top priority as their risk for chronic diseases remains disproportionately high,” said Luján, a member of the Senate Committee on Indian Affairs. “I'm pleased this investment of more than $1 million will support the Albuquerque Area Indian Health Board in developing and providing stronger preventative disease services and will help keep Indigenous communities healthy.”
“Many chronic disease risk factors disproportionately impact Tribal communities across New Mexico,“ said Stansbury. “Today, I’m proud to welcome over $1 million in federal funding that will help local Tribes to support their communities with expanded and holistic resources to encourage healthy lifestyles, improve Tribal health, and prevent chronic diseases.”
The Centers for Disease Control and Prevention (CDC) is awarding $1,240,625 to Albuquerque Area Indian Health Board. This funding was provided through the CDC’s Good Health and Wellness in Indian Country (GHWIC) program, which promotes healthy behaviors in Tribal communities and works to reduce risk factors through holistic and culturally appropriate approaches. The program’s long-term goals include reducing rates of type 2 diabetes, commercial tobacco use, high blood pressure, and high blood cholesterol.